Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

PAR-21-252: Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Closed Closed October 14, 2024 Opportunity PAR-21-252

This grant is closed. A newer notice from the same program is open now: Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) (PAR-24-296). Status: Due dates in the notice, expires December 3, 2026. It is in our archive of National Institutes of Health notices from 2021.

National Institutes of Health offered grants to the applicants described in the notice. Applications closed on October 14, 2024.

From the official notice on Grants.gov, last changed October 15, 2024. Checked November 7, 2026.

About this NIH notice

Projects funded under PAR-21-252 were run by John E. Fogarty International Center for Advanced Study in the Health Sciences (FIC, 28 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read PAR-21-252 in the NIH Guide.

Other notices with this title

National Institutes of Health has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
PAR-24-296October 15, 2024Due dates in the notice, expires December 3, 2026Open

Key dates

PostedSeptember 8, 2021
DeadlineOctober 14, 2024
Archived by Grants.govNovember 13, 2024

Who can apply

This opportunity was open to the applicants described in the notice.

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Is this a realistic fit?

What the grant funds

This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA PAR-. The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups , including low-income, lower-middle-income, and upper-middle-income countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.

Category: Education, Environment, Health.

Funded under PAR-21-252 so far

NIH funded 28 projects under PAR-21-252 in fiscal 2022 to 2026, at 20 institutions. The median yearly award was $102,502.

Most projects: Stellenbosch University, 4, University of Cape Town, 3, Mbarara University/Science/ Technology, 2, The Botswana Harvard Health Partnership, 2, College of Medicine, University of Lagos, 2.

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before

From fiscal 2021 to 2025, Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) awarded $9.1 billion across 8,641 grant awards, an average of $1.0 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The General Hospital CorporationMassachusetts203$288 million
The Regents of the University of California, San FranciscoCalifornia248$277 million
The Johns Hopkins UniversityMaryland230$276 million
The Trustees of Columbia University in the City of New YorkNew York188$226 million
Regents of the University of MichiganMichigan179$221 million

Top states: California ($1.4 billion), New York ($926 million), Massachusetts ($906 million), Pennsylvania ($626 million), Texas ($499 million).

Who has won Mental Health Research Grants grants before

From fiscal 2021 to 2025, Mental Health Research Grants (93.242) awarded $8.8 billion across 6,785 grant awards, an average of $1.3 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Yale UnivConnecticut185$371 million
University of Pittsburgh - of the Commonwealth System of Higher EducationPennsylvania200$297 million
University of California, Los AngelesCalifornia176$234 million
Icahn School of Medicine at Mount SinaiNew York144$212 million
The Washington UniversityMissouri149$211 million

Top states: California ($1.4 billion), Massachusetts ($1.1 billion), New York ($1.1 billion), Pennsylvania ($667 million), Connecticut ($422 million).

Who has won Human Genome Research grants before

From fiscal 2021 to 2025, Human Genome Research (93.172) awarded $2.2 billion across 1,255 grant awards, an average of $1.7 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
The Leland Stanford Junior UniversityCalifornia59$153 million
University of WashingtonWashington46$123 million
The Broad Institute, IncMassachusetts22$119 million
University of California Santa CruzCalifornia17$64.7 million
Baylor College of MedicineTexas24$62.9 million

Top states: California ($470 million), Massachusetts ($350 million), New York ($193 million), Washington ($145 million), North Carolina ($119 million).

Other programs behind this notice

Applying now

This notice no longer takes applications. Apply under the newer notice, PAR-24-296, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is PAR-21-252 still open?

No. It closed on October 14, 2024. A newer notice is open: PAR-24-296, due dates in the notice, expires December 3, 2026.

Who can apply for Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

What is the deadline for Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)?

Closed October 14, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

Who has been funded under PAR-21-252?

NIH RePORTER lists 28 projects funded under PAR-21-252 in fiscal 2022 to 2026, at 20 institutions. The most were at Stellenbosch University, University of Cape Town, Mbarara University/Science/ Technology.

Who has won Environmental Health grants before?

The largest recipients over five fiscal years were Icahn School of Medicine at Mount Sinai, The Trustees of Columbia University in the City of New York, University of North Carolina at Chapel Hill. The program made 1,980 awards worth $2.1 billion in that time.

Similar open grants